Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Tuberous Sclerosis × Sirolimus × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hematologic Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Rhabdomyosarcoma 3 Neoplasms 3 Sarcoma, Ewing 2 Sarcoma 2 Rhabdoid Tumor 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroblastoma 2 Neoplasms, Germ Cell and Embryonal 2 Myelodysplastic Syndromes 2 Melanoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Bronchiolitis Obliterans Syndrome 2 Brain Neoplasms 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Tufted angioma 1 Tuberous Sclerosis 1 Thrombocytopenia 1 Skin Neoplasms 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Refractory Solid Tumors in Children 1 Recurrence 1 Pseudomyxoma Peritonei 1 Pinealoma 1 PRETEXT I Hepatoblastoma 1

Interventions

Everolimus 3 Cannabidiol 3 exemestane 1 carbon-11 acetate 1 Solutions 1 Sirolimus 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05104983 2026-01-22

TSC-STEPS

Children's Hospital Medical Center, Cincinnati

Phase 2 Recruiting

Epilepsy, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡